SCHAUMBURG, Ill., June 02, 2025--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Leuprolide Acetate ...

Cipla Limited and its wholly owned subsidiary Cipla USA Inc. on Tuesday has announced the launch of Leuprolide Acetate Injection Depot 22.5mg. The product was approved by the United States Food and ...

Cipla Limited and its wholly owned subsidiary Cipla USA Inc., has announced the launch of leuprolide acetate injection depot 22.5mg. The product was approved by the United States Food and Drug ...

Camcevi is a ready-to-use 6-month subcutaneous depot formulation of leuprolide mesylate, a gonadotropin-releasing hormone agonist. Camcevi ® (leuprolide mesylate) 42mg injection is now available for ...

Aurobindo Pharma Limited announced that its wholly-owned subsidiary company, Eugia Pharma Specialties Limited, has received final approval from the US Food & Drug Administration (USFDA) to manufacture ...

Leuprolide Acetate injection is indicated in the palliative treatment of advanced prostatic cancer. Leuprolide Acetate injections will be manufactured at the Company's oncology injectable ...

The Food and Drug Administration has cleared Amneal’s leuprolide acetate for injection, which is indicated in the palliative treatment of advanced prostatic cancer. “We are making tremendous progress ...

New Delhi, Nov 14 (PTI) Zydus Lifesciences Ltd on Friday said it has received final approval from the US health regulator for its generic version of Leuprolide Acetate injection used in palliative ...

Key Companies Covered in the Leuprolide Acetate Research are Beijing Biote, Takeda, Sun Pharmaceutical, Livzon, Soho-Yiming, Bachem, TOLMAR, Varian Pharmed and other key market players. The Leuprolide ...